# Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature

> **NCT04798690** · — · RECRUITING · sponsor: **Dong-A ST Co., Ltd.** · enrollment: 2500 (estimated)

## Conditions studied

- Growth Hormone Deficiency
- Idiopathic Short Stature
- Turner Syndrome
- Small for Gestational Age

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04798690
- **Lead sponsor:** Dong-A ST Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-02-08
- **Primary completion:** 2031-12
- **Final completion:** 2031-12
- **Target enrollment:** 2500 (ESTIMATED)
- **Last updated:** 2023-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04798690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04798690, "Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04798690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*